Aims and Scope
Aim of the journal is to publish qualified research material on its scope. The target readership includes academic members or specialists on medicine and oncology. Scope of the journal covers medicine and oncology.
EJMO publishes articles following a double-blind peer review mechanism to ensure the standards of its publications.
Basic Publication Rules
Authors are responsible for the accuracy of data and the journal is in compliance with the uniform requirements for manuscripts submitted to biomedical journals published by the ICMJE. The editorial and publication processes of the journal are conducted in accordance with the guidelines of the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the European Association of Science Editors (EASE), and the Committee on Publication Ethics (COPE) as well.
Statements or opinions expressed in the manuscripts published in Eurasian Journal of Medicine and Oncology reflect the views of the author(s) and not the opinions of the editors, the editorial board and the publisher; the editors, the editorial board and the publisher disclaim any responsibility or liability for such materials.
Abstracting and Indexing
EJMO is being evaluated by EBSCOhost, DOAJ, ESCI and TUBITAK TR Index.
There is no fee for article submission, article processing or publication.
Revenue source only of EJMO journal consist of advertisements of institutional pharmaceutical companies that are only available in the print version.
There is a printed version of each issue. In printed version can not exceed 5 full page ads.
Companies that advertise in printed version in 2017 of Journal AMGEN, MERCK, NOVARTIS, SANOFIi, AVENTIS, ASTELLAS and TR PHARM.
Access to Journal Content
The abstracts and full texts of published articles can be accessed free of charge at www.ejmo.org www.ejmo.org